| |
| |
|
| Insider
Information: |
Lochner Daniel |
| Relationship: |
Chief Financial Officer |
| City: |
Princeton |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Oyster Point Pharma, Inc. |
OYST |
Chief Financial Officer |
2023-01-03 |
0 |
2019-11-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OYST |
Oyster Point Pharma, Inc. |
Chief Financial Officer |
• – – |
2023-01-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(20,236) |
0 |
0 |
- |
|
| OYST |
Oyster Point Pharma, Inc. |
Chief Financial Officer |
• – – |
2023-01-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(56,289) |
20,236 |
0 |
- |
|
| OYST |
Oyster Point Pharma, Inc. |
Chief Financial Officer |
• – – |
2022-12-01 |
4 |
D |
$11.20 |
$36,490 |
D/D |
(3,258) |
74,463 |
0 |
- |
|
| OYST |
Oyster Point Pharma, Inc. |
Chief Financial Officer |
• – – |
2022-01-29 |
4 |
D |
$11.70 |
$10,975 |
D/D |
(938) |
76,525 |
0 |
- |
|
| OYST |
Oyster Point Pharma, Inc. |
Chief Financial Officer |
• – – |
2022-01-09 |
4 |
A |
$0.00 |
$0 |
D/D |
19,500 |
77,721 |
0 |
- |
|
| OYST |
Oyster Point Pharma, Inc. |
Chief Financial Officer |
• – – |
2021-11-01 |
4 |
OE |
$11.51 |
$98,871 |
D/D |
8,590 |
58,221 |
0 |
- |
|
| OYST |
Oyster Point Pharma, Inc. |
Chief Financial Officer |
• – – |
2021-09-02 |
4 |
OE |
$11.51 |
$86,325 |
D/D |
7,500 |
49,631 |
0 |
- |
|
| OYST |
Oyster Point Pharma, Inc. |
Chief Financial Officer |
• – – |
2021-07-28 |
4 |
OE |
$11.51 |
$86,325 |
D/D |
7,500 |
42,131 |
0 |
- |
|
| OYST |
Oyster Point Pharma, Inc. |
Chief Financial Officer |
• – – |
2021-02-24 |
4 |
OE |
$11.51 |
$104,845 |
D/D |
9,109 |
34,631 |
0 |
- |
|
| OYST |
Oyster Point Pharma, Inc. |
Chief Financial Officer |
• – – |
2021-01-29 |
4 |
A |
$0.00 |
$0 |
D/D |
11,222 |
25,522 |
0 |
- |
|
| OYST |
Oyster Point Pharma, Inc. |
Chief Financial Officer |
• – – |
2020-09-25 |
4 |
OE |
$11.51 |
$46,040 |
D/D |
4,000 |
14,300 |
0 |
- |
|
| OYST |
Oyster Point Pharma, Inc. |
Chief Financial Officer |
• – – |
2020-08-11 |
4/A |
OE |
$11.51 |
$46,040 |
D/D |
4,000 |
10,300 |
0 |
- |
|
| OYST |
Oyster Point Pharma, Inc. |
Chief Financial Officer |
• – – |
2020-08-11 |
4 |
OE |
$11.51 |
$46,040 |
D/D |
4,000 |
4,000 |
0 |
- |
|
| OYST |
Oyster Point Pharma, Inc. |
Chief Financial Officer |
• – – |
2019-11-04 |
4 |
B |
$16.00 |
$100,800 |
D/D |
6,300 |
6,300 |
2.74 |
- |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
